Search research articles
Contact Us
Filters
Showing results (51-60 of 82) with videos related to
Page
of 9
Sort By:
The New England Journal of Medicine
|
April 20, 2001
Cognitive function in postmenopausal women treated with raloxifene
K Yaffe, K Krueger, S Sarkar, et al.
Archives of Environmental Contamination and Toxicology
|
October 6, 1999
Comparative toxicity of fluoranthene to freshwater and saltwater species under fluorescent and ultraviolet light
R L Spehar, S Poucher, L T Brooke, et al.
FEBS Letters
|
May 25, 1992
Crystallization and preliminary X-ray analysis of recombinant human transforming growth factor beta 2
M P Schlunegger, N Cerletti, D A Cox, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 26, 1998
Comment on lack of effect of raloxifene on coronary artery atherosclerosis of postmenopausal monkeys
H U Bryant, R F Kauffman, P Iversen, et al.
Maturitas
|
July 14, 2001
Effects of raloxifene and hormone replacement therapy on markers of serum atherogenicity in healthy postmenopausal women
P W Anderson, D A Cox, A Sashegyi, et al.
European Journal of Pharmacology
|
January 3, 2001
Raloxifene, an oestrogen-receptor modulator, prevents decreased constitutive nitric oxide and vasoconstriction in ovariectomized rats
I Pávó, F László, E Morschl, et al.
Journal of the American College of Cardiology
|
November 1, 1989
Control of shear stress in the epicardial coronary arteries of humans: impairment by atherosclerosis
J A Vita, C B Treasure, P Ganz, et al.
The Journal of Clinical Investigation
|
August 1, 1989
Reflex increase in blood pressure during the intracoronary administration of adenosine in man
D A Cox, J A Vita, C B Treasure, et al.
Clinical Therapeutics
|
October 9, 2001
Effect of raloxifene on serum triglycerides in postmenopausal women: influence of predisposing factors for hypertriglyceridemia
L Mosca, K Harper, S Sarkar, et al.
The American Journal of Cardiology
|
October 9, 2001
Role of tumor necrosis factor-alpha and interleukin-6 in the effects of hormone replacement therapy and raloxifene on C-reactive protein in postmenopausal women
B W Walsh, D A Cox, A Sashegyi, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 82) with videos related to
Sort By:
Page
of 9
The New England Journal of Medicine
|
April 20, 2001
Cognitive function in postmenopausal women treated with raloxifene
K Yaffe, K Krueger, S Sarkar, et al.
Archives of Environmental Contamination and Toxicology
|
October 6, 1999
Comparative toxicity of fluoranthene to freshwater and saltwater species under fluorescent and ultraviolet light
R L Spehar, S Poucher, L T Brooke, et al.
FEBS Letters
|
May 25, 1992
Crystallization and preliminary X-ray analysis of recombinant human transforming growth factor beta 2
M P Schlunegger, N Cerletti, D A Cox, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 26, 1998
Comment on lack of effect of raloxifene on coronary artery atherosclerosis of postmenopausal monkeys
H U Bryant, R F Kauffman, P Iversen, et al.
Maturitas
|
July 14, 2001
Effects of raloxifene and hormone replacement therapy on markers of serum atherogenicity in healthy postmenopausal women
P W Anderson, D A Cox, A Sashegyi, et al.
European Journal of Pharmacology
|
January 3, 2001
Raloxifene, an oestrogen-receptor modulator, prevents decreased constitutive nitric oxide and vasoconstriction in ovariectomized rats
I Pávó, F László, E Morschl, et al.
Journal of the American College of Cardiology
|
November 1, 1989
Control of shear stress in the epicardial coronary arteries of humans: impairment by atherosclerosis
J A Vita, C B Treasure, P Ganz, et al.
The Journal of Clinical Investigation
|
August 1, 1989
Reflex increase in blood pressure during the intracoronary administration of adenosine in man
D A Cox, J A Vita, C B Treasure, et al.
Clinical Therapeutics
|
October 9, 2001
Effect of raloxifene on serum triglycerides in postmenopausal women: influence of predisposing factors for hypertriglyceridemia
L Mosca, K Harper, S Sarkar, et al.
The American Journal of Cardiology
|
October 9, 2001
Role of tumor necrosis factor-alpha and interleukin-6 in the effects of hormone replacement therapy and raloxifene on C-reactive protein in postmenopausal women
B W Walsh, D A Cox, A Sashegyi, et al.
Page
of 9